Aker BioMarine AS engages in harvesting krill and supplies krill-derived products worldwide. It operates through two segments, Ingredients and Brands. The Ingredients segment is involved in the offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products for nutraceutical, pet food, and aquaculture industries. The Brands segment produces and distributes private label vitamins and supplements to retailers. The company provides Superba, a krill oil; QRILL Aqua, an ingredient for formulated feeds; FloraMarine, a plant-based marine source of DHA omega-3 from algae; and QRILL Pet, a functional marine ingredient for pets. It also offers LYSOVETA, a supplement product for brain health; and Understory, a protein peptides product. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles plastic products. The company was founded in 2006 and is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.
Metrics to compare | AKBM | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipAKBMPeersSector | |
---|---|---|---|---|
P/E Ratio | −35.5x | −0.9x | 11.7x | |
PEG Ratio | −0.36 | 0.00 | 0.03 | |
Price/Book | 1.1x | 0.8x | 1.5x | |
Price / LTM Sales | 1.2x | 0.6x | 0.9x | |
Upside (Analyst Target) | 76.0% | 547.9% | 15.8% | |
Fair Value Upside | Unlock | 10.0% | 7.9% | Unlock |